Innovation in Flux
May 7, 2015
Over 70 percent of pharma leaders admit their business relies heavily on fading revenue streams – but how can we promote much-needed innovation in the current climate of uncertainty?
1 min read
Manufacture
Business & Trends
Development & Clinical
Drug Delivery
Formulation
Small Molecules
Sponsored
The big reveal: Workhorse + Innovation = more information (Part 1)
May 7, 2015
A concern raised by the rise in routine MRI screening within the healthcare industry is that the ability to detect abnormalities within the body may currently be running ahead of our understanding of their possible consequences, making it difficult to determine a sound course of action. Here then analytical science is arguably advancing beyond current requirements.
1 min read
Beyond SOPs – Exploring the rigor and requirements of Analytical QbD
May 7, 2015
Analytical QbD (AQbD) promises to extend the rigor and benefits of QbD into the area of analytical method development. Here, Paul Kippax provides an introduction to the methodology involved and takes as an example the application of AQbD to the development of a laser diffraction particle sizing method.
1 min read
Protecting Intellectual Property
May 5, 2015
When it comes to IP, large companies regularly trample over the rights of smaller firms. But by playing the game, it is possible for a small company to make IP a core revenue stream.
1 min read
Eye on the Prize
May 5, 2015
Sitting Down With... Dirk Sauer, Novartis’ Global Head, Development Franchise Ophthalmics.
1 min read
The Big Leap from Academic to Entrepreneur
May 5, 2015
If you want to launch a new drug company, you’ll need experience, drive and excellent science… not to mention a great deal of perseverance.
1 min read
Making Room for Improvement
May 5, 2015
To make way for more flexible approved analytical methods in pharma, we need a better understanding of the underlying scientific principles.
1 min read
The Post-Antibiotic Phage
May 5, 2015
Will bacteriophages be the savior of the human race in the post-antibiotic era or is it just pie in the sky?
1 min read
‘Fingerprinting’ Drug Labels to Fight Fraud
May 5, 2015
Using tiny imperfections in the printing process to track individual products through the supply chain
1 min read
Enzyme Evolution
May 5, 2015
By mimicking natural evolution of enzymes, researchers are creating biocatalysts for reactions unheard of in nature
1 min read
To Err is Human
May 5, 2015
But can pharma manufacturers do more to help prevent medication errors?
1 min read
Ebola’s Genomic Drift
May 5, 2015
Media attention on Ebola has largely abated, but the outbreak is not over yet. What impact will genetic changes have on new medicines currently in development?
1 min read
Generic Love Triangle
May 5, 2015
It’s the timeless story: Teva wants Mylan, Mylan wants Perrigo, and Perrigo wants none of it
1 min read
Cutting the Cost of Antibodies
May 5, 2015
By eliminating protein A, researchers aim to deliver continuous processing at a fraction of the cost of conventional techniques
1 min read
The Power of the List
May 5, 2015
Celebrating medicine makers of all stripes in our Top 100
1 min read
